Evidence map›Paper›PMID 25741874›Full record

ArticleThe American journal of managed care2014

Medicare Star excludes diabetes patients with poor CVD risk factor control.

Julie Schmittdiel, Marsha Raebel, Wendy Dyer, John Steiner, Glenn Goodrich, Andy Karter, Gregory Nichols

Abstract read
In one paragraph

Article in The American journal of managed care, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Effects of Part D Star Ratings on racial and ethnic disparities in health care costs.Exploratory research in clinical and social pharmacy · 2023
    Article
  3. Article
  4. Increasing Equity While Improving the Quality of Care: JACC Focus Seminar 9/9.Journal of the American College of Cardiology · 2021
    Review
  5. Article
  6. Article
  7. Observational
  8. Observational
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Julie SchmittdielKaiser Permanente, 2000 Broadway, Oakland, CA 94612. E-mail: Julie.A.Schmittdiel@kp.org.
Marsha Raebel
Wendy Dyer
John Steiner
Glenn Goodrich
Andy Karter
Gregory Nichols
Kaiser Permanente · US

Funding

Translational Research Core - Health Engagement & Action Translational (HEAT)P30DK092924 · NIDDK · KAISER FOUNDATION RESEARCH INSTITUTE · PI Alyce Sophia Adams, HILARY Kessler SELIGMAN · 2011 to 2026
$9.2M
Multi-institutional Consortium for CER in Diabetes Treatment and PreventionR01HS019859 · AHRQ · KAISER FOUNDATION RESEARCH INSTITUTE · PI STEINER, JOHN F · 2010 to 2010
$8.9M
AHRQ HHS R01 HS019859AHRQ HHS R01HS019859NIDDK NIH HHS 1P30-DK092924NIDDK NIH HHS P30 DK092924
6 · The paper itself

Abstract

objectivesCMS recently added medication adherence to antihypertensives, antihyperlipidemics, and oral antihyperglycemics to its Medicare Star quality measures. These CMS metrics exclude patients with <2 medication fills (ie, "early nonadherence") and patients concurrently taking insulin. This study examined the proportion of patients with diabetes prescribed cardiovascular disease (CVD) medications excluded from Star adherence metrics and assessed the relationship of both Star-defined adherence and exclusion from Star metrics with CVD risk factor control. STUDY

designCross-sectional, population-based analysis of 129,040 patients with diabetes aged ≥65 years in 2010 from 3 Kaiser Permanente regions.

methodsWe estimated adjusted risk ratios to assess the relationship between achieving Star adherence and being excluded from Star adherence metrics, with CVD risk factor control (glycated hemoglobin [A1C]<8.0%, low-density lipoprotein cholesterol [LDL-C]<100 mg/dL, and systolic blood pressure [SBP]<130 mm Hg) in patients with diabetes.

resultsStar metrics excluded 27% of patients with diabetes prescribed oral medications. Star-defined nonadherence was negatively associated with CVD risk factor control (risk ratio [RR], 0.95, 0.84, 0.96 for A1C, LDL-C, and SBP control, respectively; P<.001). Exclusion from Star metrics due to early nonadherence was also strongly associated with poor control (RR, 0.83, 0.56, 0.87 for A1C, LDL-C, and SBP control, respectively; P<.001). Exclusion for insulin use was negatively associated with A1C control (RR, 0.78; P<.0001).

conclusionsMedicare Star adherence measures underestimate the prevalence of medication nonadherence in diabetes and exclude patients at high risk for poor CVD outcomes. Up to 3 million elderly patients with diabetes may be excluded from these measures nationally. Quality measures designed to encourage effective medication use should focus on all patients treated for CVD risk.

Indexed as

AgedAged, 80 and overCardiovascular DiseasesCross-Sectional StudiesDiabetes MellitusDrug MonitoringFemaleHumansHypoglycemic AgentsMaleMedicareQuality Indicators, Health CareRisk FactorsUnited StatesHypoglycemic Agents

Identifiers

PMID25741874
PMCPMC4641517
OpenAlexW115547701

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.